Notice of AGM
CRISM Therapeutics Corporation has announced that its Annual General Meeting will be held on Tuesday, October 27, 2026, at 11:00 am. The company, focused on localized chemotherapy drug delivery, has also commenced recruitment for its Phase 2 clinical trial of irinotecan-ChemoSeed for glioblastoma patients, a significant step in its development pipeline.
Select text to share a quote on X · sign in to keep highlights & notes in your CRTX notes
CRISM Therapeutics Corporation (AIM: CRTX), a UK clinical-stage drug delivery company focused on the localised and sustained delivery of chemotherapy drugs, confirms that the Annual General Meeting ("AGM") will take place at 11:00am on Tuesday 27 October 2026 at the offices of Fieldfisher LLP, Riverbank House, 2 Swan Lane, London EC4R 3TT. Further details are set out in the Notice of AGM which has been posted to shareholders today.
A copy Notice of AGM can be accessed from the Company´s website at:
The Company's LEI is 213800XFW6MKVCHHPW88.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.